Select for export How to account for hallucinations in the interpretation of the antidepressant effects of psychedelics: a translational framework. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-022-06106-8 PubMed 35348806 Copy citation Copy BibTeX Psychopharmacology 2022-05-31 van den Berg M, Magaraggia I, Schreiber R, Hillhouse TM, Porter JH PubMed Published psilocybin DepressionPharmacologyMystical Experience Other More
Select for export Postpartum depression: A role for psychedelics? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811221093793 PubMed 35638179 Copy citation Copy BibTeX Unknown journal 2022-05-29 Jairaj C, Rucker JJ. Europe PMC Published psilocybin DepressionAgingReview Article Review Article More
Select for export Unraveling the Mysteries of Mental Illness With Psilocybin. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.7759/cureus.25414 PubMed 35769681 Copy citation Copy BibTeX Unknown journal 2022-05-26 Sotille R, Singh H, Weisman A, Vida T. Europe PMC Published psilocybinpsilocin DepressionNeuroplasticityReceptor Pharmacology Clinical Trial More
Select for export Psilocybin-Assisted Therapy Found to Improve Depression, Offer Other Benefits Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1176/appi.pn.2022.06.6.30 Copy citation Copy BibTeX Psychiatric News 2022-05-22 Richard Karel OpenAlex Published psilocybin DepressionAnxietyEnd-of-Life Distress Clinical Trial More
Select for export Psilocybin Versus Ketamine - Fast Acting Antidepressant Strategies in Treatment-resistant Depression Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2022-05-19 National Institute of Mental Health, Czech Republic ClinicalTrials.gov CLINICAL TRIAL psilocybinpsilocin DepressionNeuroplasticityBrain Imaging Clinical Trial More
Select for export Phase II, Randomized, Double Blind, Placebo Controlled, Parallel Group, Single Center Study of Psilocybin Efficacy in Major Depression Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2022-04-28 University of Zurich ClinicalTrials.gov CLINICAL TRIAL psilocybin DepressionAnxietyNeuroplasticity Clinical Trial More
Select for export P388. Open Label Psilocybin Administration in Severely Treatment Resistant Depression No abstract availability was recorded for this entry. Details DOI 10.1016/j.biopsych.2022.02.624 Copy citation Copy BibTeX Biological Psychiatry 2022-04-27 Scott Aaronson, Tammy Miller, Samuel Rudow, MacKenzie Forbes, Trisha Suppes OpenAlex Published psilocybin DepressionAnxietyClinical Trial Randomized Controlled Trial More
Select for export Diverse therapeutic developments for post-traumatic stress disorder (PTSD) indicate common mechanisms of memory modulation. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.pharmthera.2022.108195 PubMed 35489438 Copy citation Copy BibTeX Unknown journal 2022-04-26 Raut SB, Marathe PA, van Eijk L, Eri R, Ravindran M, Benedek DM Europe PMC Published psilocybin DepressionAnxietyPTSD Clinical Trial More
Select for export Increased global integration in the brain after psilocybin therapy for depression. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41591-022-01744-z PubMed 35411074 Copy citation Copy BibTeX Nature Medicine 2022-04-10 Daws RE, Timmermann C, Giribaldi B, Sexton JD, Wall MB, Erritzoe D Europe PMC Published psilocybin DepressionBrain ImagingReceptor Pharmacology Randomized Controlled Trial More
Select for export Methodological challenges in psychedelic drug trials: Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) - Rationale and study design. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.nsa.2022.100104 PubMed 40656230 Copy citation Copy BibTeX Neuroscience Applied 2022-03-06 Mertens LJ, Koslowski M, Betzler F, Evens R, Gilles M, Jungaberle A Europe PMC Published psilocybin DepressionClinical TrialSafety Clinical Trial More
Select for export Psilocybin: Characterization of the Metastable Zone Width (MSZW), Control of Anhydrous Polymorphs, and Particle Size Distribution (PSD). Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1021/acsomega.1c06708 PubMed 35187358 Copy citation Copy BibTeX ACS Omega 2022-02-06 Kargbo RB, Sherwood AM, Meisenheimer P, Lenoch K, Abebe S. Europe PMC Published psilocybinpsilocin DepressionClinical TrialTreatment-Resistant Depression Clinical Trial More
Select for export Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811211073759 PubMed 35166158 Copy citation Copy BibTeX Journal of Psychopharmacology 2022-01-31 Gukasyan N, Davis AK, Barrett FS, Cosimano MP, Sepeda ND, Johnson MW Europe PMC Published psilocybin DepressionWellbeingSpirituality Clinical Trial More
Select for export Psychedelic-assisted psychotherapy for the treatment of major depression: a synthesis of phenomenological explanations. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s11019-022-10070-7 PubMed 35064398 Copy citation Copy BibTeX Unknown journal 2022-01-21 Miceli McMillan R, Jordens C. Europe PMC Published psilocybin Depression Other More
Select for export Novel Antidepressants in the Pipeline (Phase II and III): A Systematic Review of the US Clinical Trials Registry. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1055/a-1714-9097 PubMed 35045580 Copy citation Copy BibTeX Unknown journal 2022-01-18 Sakurai H, Yonezawa K, Tani H, Mimura M, Bauer M, Uchida H. Europe PMC Published psilocybin DepressionMechanism of ActionClinical Trial Systematic Review More
Select for export Neurochemical properties of psilocybin in comparison to ketamine in vivo No abstract availability was recorded for this entry. Details DOI 10.1016/j.nsa.2022.100408 Copy citation Copy BibTeX Neuroscience Applied 2021-12-31 A. Wojtas, A. Bysiek, Z. Szych, M. Herian, K. Gołembiowska OpenAlex Published psilocybin DepressionPharmacologyReceptor Pharmacology Other More
Select for export Psilocybin may be effective for treatment-resistant depression Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1211/pj.2022.1.164911 Copy citation Copy BibTeX Pharmaceutical journal/The pharmaceutical journal 2021-12-31 Authors unavailable OpenAlex Published psilocybin DepressionClinical TrialTreatment-Resistant Depression Clinical Trial More
Select for export The efficacy of COMP360 psilocybin therapy in treatment-resistant depression: exploratory results from a phase IIb randomised controlled trial No abstract availability was recorded for this entry. Details DOI 10.1016/j.nsa.2022.100213 Copy citation Copy BibTeX Neuroscience Applied 2021-12-31 G. Goodwin, Scott T. Aaronson, Boadie W. Dunlop, D. Feifel, David J. Hellerstein, L. Marwood OpenAlex Published psilocybin DepressionClinical TrialRandomized Controlled Trial Randomized Controlled Trial More
Select for export The safety and efficacy of COMP360 psilocybin therapy in treatment-resistant depression: results from a phase IIb randomised controlled trial No abstract availability was recorded for this entry. Details DOI 10.1016/j.nsa.2022.100511 Copy citation Copy BibTeX Neuroscience Applied 2021-12-31 G.M. Goodwin, Scott T. Aaronson, Boadie W. Dunlop, David Feifel, David J. Hellerstein, N. Hewitt OpenAlex Published psilocybin DepressionClinical TrialRandomized Controlled Trial Randomized Controlled Trial More
Select for export Psilocybin for the Treatment of Depression: A Promising New Pharmacotherapy Approach. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/7854_2021_282 PubMed 34811715 Copy citation Copy BibTeX Current topics in behavioral neurosciences 2021-12-31 Agin-Liebes G, Davis AK. Europe PMC Published psilocybin DepressionBrain ImagingAging Clinical Trial More
Select for export Serotonergic psychedelics for depression: What do we know about neurobiological mechanisms of action? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2022.1076459 PubMed 36844032 Copy citation Copy BibTeX Frontiers in psychiatry 2021-12-31 Husain MI, Ledwos N, Fellows E, Baer J, Rosenblat JD, Blumberger DM PubMed Published psilocybin DepressionBrain ImagingMechanism of Action Review Article More
